Pragmatic Recommendations for Therapeutics of Hospitalized COVID-19 Patients in Low- and Middle-Income Countries

The therapeutic options for COVID-19 patients are currently limited, but numerous randomized controlled trials are being completed, and many are on the way. For COVID-19 patients in low- and middle-income countries (LMICs), we recommend against using remdesivir outside of a clinical trial. We recomm...

Descripción completa

Detalles Bibliográficos
Autores principales: Shetty, Varun U., Brotherton, Brian Jason, Achilleos, Andrew, Akrami, Kevan M., Barros, Lia M., Checkley, William, Cobb, Natalie, Maximous, Stephanie, Misango, David, Park, Casey, Taran, Shaurya, Lee, Burton W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The American Society of Tropical Medicine and Hygiene 2021
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7957231/
https://www.ncbi.nlm.nih.gov/pubmed/33377451
http://dx.doi.org/10.4269/ajtmh.20-1106

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7957231/
https://www.ncbi.nlm.nih.gov/pubmed/33377451
http://dx.doi.org/10.4269/ajtmh.20-1106

Ejemplares similares